Why ACGT’s Work Matters More Than Ever – A Look At Glioblastoma After John McCain’s Passing

  • | Aug 30 2018 |

By Margaret C. Cianci

As many of you know, elder statesman Senator John McCain passed away this week at age 81 after his last battle – this one against glioblastoma, an insidious type of brain cancer.

Read More

Are there CAR T Cell Therapy Clinical Trials?

  • | Jul 31 2018 |

Currently, there are ongoing trials for Car T Cell therapy to treat different types of cancer. Before any trial is conducted, researches work endlessly for years to understand how the treatment works in a lab with animals.

Read More

Cancer Vaccines: Early Beginnings

  • | May 25 2017 |

At the ACGT anniversary gala in April, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research and newly appointed Director of the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania,

Read More

Philanthropists Make Miracles Happen

  • | Jan 27 2017 |

You might be surprised to learn that only one percent of grant funding from the National Institutes of Health [NIH] is awarded to young researchers. In contrast, ACGT uses half of its funding for clinical trials and half of its funding goes to young scientists exploring revolutionary approaches to cancer treatment.

Read More

OV Therapy – The Next Frontier is Closer Than You Think

  • | Sep 21 2016 |

This fourth in our blog series on the progress of cell and gene therapy for cancer focuses on a treatment that has made huge strides in recent years: Viral Therapy.

What is Viral Therapy?

Read More

CRISPR the Next Frontier in Gene Therapy Cancer Research

  • | Sep 06 2016 |

In our last blog, we described the progress and promise of CAR T, an immunotherapy that has been particularly successful with leukemia and lymphoma. As a companion to CAR T, and all forms of cell and gene therapies,

Read More

Immunotherapy and Cell Therapy Research For Cancer Makes Headlines

  • | Aug 12 2016 |

In the third of a front page series in the The New York Times published July 31st – August 2nd, entitled “Setting the Body’s ‘Serial Killers’ Loose on Cancer,” science writer Andrew Pollack reported on Dr.

Read More

Witness to Cancer Research Progress

  • | Jul 27 2016 |

We recently participated in a webinar sponsored by FasterCures featuring highlights of the Cancer Moonshot Summit in Washington, D.C. You may recall the Moonshot is the initiative announced at President Obama’s State of the Union Address in January,

Read More

Wendy Walk and ACGT Join Forces

  • | May 03 2016 |

Sunday, May 1, 2016, ACGT colleagues attended the Wendy Walk Fundraiser in New York City. This uplifting event is another example of the difference a few people and a good idea can make. Wendy Walk was founded in 2010 by ACGT Board Member Ali Landes and siblings Matt and Jackie to raise funds and awareness for sarcomas,

Read More